Stock Taper
EARNINGS CALL ARCHIVE 3 CALLS ON FILE
NAGE — Niagen Bioscience Inc
NASDAQ
FULL STOCK PAGE →

Q1 2026 Earnings Call Summary

MAY 6, 2026
REVENUE
$31.5M -7.0%
NET MARGIN
20.1% +7.9 PTS
EPS
$0.08 +51.2%
FREE CASH FLOW
-$1.3M -317.1%

No summary has been written for this call yet.